The GH-IGF1 axis and longevity. The paradigm of IGF1 deficiency

Hormones

Volumn 7, Issue 1, 2008, Pages 24-27

  Laron, Zvi ^a,b  

^a SCHNEIDER CHILDREN S MEDICAL CENTER OF ISRAEL   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

Aging; GH deficiency; IGF1 deficiency; Insulin; Insulin sensitivity; Lifespan; Longevity

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; SOMATOMEDIN C; HUMAN GROWTH HORMONE;

CAENORHABDITIS ELEGANS; CAUSE OF DEATH; DROSOPHILA; DWARFISM; ECUADOR; GENE INACTIVATION; HUMAN; HYPERLIPIDEMIA; INSULIN RESISTANCE; INVERTEBRATE; ISRAEL; LARON SYNDROME; LIFESPAN; LONGEVITY; MISSENSE MUTATION; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OBESITY; POPULATION; PROTECTION; PROTEIN DEFICIENCY; PROTEIN SECRETION; REVIEW; RODENT; SOMATOMEDIN C DEFICIENCY; GENETICS; PATHOPHYSIOLOGY; PHYSIOLOGY;

HUMAN GROWTH HORMONE; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LARON SYNDROME; LONGEVITY; NEOPLASMS;

EID: 42449087698     PISSN: 11093099     EISSN: None     Source Type: Journal    
DOI: 10.14310/horm.2002.1111034     Document Type: Review

References (33)

1. Laron Z, 2005 Do deficiencies in growth hormone and insulin-like growth factor-1 (IGF-1) shorten or prolong longevity? Mech Ageing Dev 126: 305-307.
2. Besson A, Salemi S, Gallati S, et al, 2003 Reduced longevity in untreated patients with isolated growth hormone deficiency. J Clin Endocinol Metab 88: 3664-3667. (Pubitemid 37034511)
3. Silbergeld A, Litwin A, Bruchis S, Varsano I, Laron Z, 1986 Insulin like growth factor I (IGF1) in healthy children, adolescents and adults as determined by a radioimmunoassay specific for the synthetic 53-70 peptide region. Clin Endocrinol 25: 67-74. (Pubitemid 16057665)
4. Blum WF 2000 Insulin-like growth factors (IGF) and IGF-binding proteins: their use for diagnosis of growth hormone deficiency. In:Juul Jorgensen JOL (eds) Growth hormone in adults, Cambridge University Press Cambridge; pp. 54-86.
5. Jneid H, Bhatt DL, 2003 Advances in antiplatelet therapy. Expert Opin Emerg Drugs 8: 349-363.
6. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ, 2003 Overweight, obesity and mortality from cancer in a prospectively studied cohort of US adults. N Engl J Med 348: 1625-1638. (Pubitemid 36459468)
7. Orme S, McNally RJQ, Cartwright RA, Belchetz PE, 1998 Mortality and cancer incidence in acromegaly: a retrospective cohort study. J Clin Endocrinol Metab 83: 2730-2734. (Pubitemid 28493768)
8. Sotelo AI, Bartke A, Turyn D, 1993 Effects of bovine growth hormone (GH) expression in transgenic mice on serum and pituitary immunoreactive mouse GH levels and pituitary GH-releasing factor binding sites. Acta Endocrinol 129: 446-452. (Pubitemid 2010960)
9. Cecim M, Bartke A, Yun JS, Wagner TE, 1994 Expression of human, but not bovine growth hormone genes promotes development of mammary tumors in transgenic mice. Transgenics 1: 431-437.
10. Bartke A, 2003 Can growth hormone (GH) accelerate aging? Evidence from GH-transgenic mice. Neuroendocrinology 78: 210-216. (Pubitemid 37409835)
11. Kimura KD, Tissenbaum HA, Liu Y, RuvkunG, 1997 daf-2 an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 277: 942-946.
12. Murphy CT, McCarroll SA, Bargmann CI, et al, 2003 Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature 424: 277-283.
13. Clancy DJ, Gems D, Harshman LG, et al, 2001 Extension of life span by loss of CHICO, a Drosophila insulin receptor substrate protein. Science 292: 104-106. (Pubitemid 32289136)
14. Holzenberger M, Dupont J, Ducos B, et al, 2003 IGF1 receptor regulates lifespan and resistance to oxidative stress in mice. Nature 421: 182-187. (Pubitemid 36090987)
15. Flurkey K, Papaconstantinou J, Miller RA, Harrison DE, 2001 Lifespan extension and delayed immune and collagen aging in mutant mice with defects in growth hormone production. Proc Natl Acad Sci USA 98: 6736-6741. (Pubitemid 32538286)
16. Zhou Y, Xu BC, Maheshwari HG, et al, 1997 A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor binding protein gene (the Laron mouse). Proc Natl Acad Sci USA 94: 13215-13220. (Pubitemid 27518502)
17. Coschigano KT, Clemmons D, Bellush LL, Kopchick JJ, 2000 Assessment of growth parameters and life span of GHR/BP gene disrupted mice. Endocrinology 141: 2608-2613. (Pubitemid 32269083)
18. Laron Z, 2004 Laron syndrome (Primary growth hormone resistance or insensitivity): The personal experience 1958-2003. J Clin Endocrinol Metab 89: 1031-1044. (Pubitemid 38368385)
19. Laron Z, Ginsberg S, Lilos P, Arbiv M, Vaisman N, 2006 Body composition in untreated adult patients with Laron syndrome (primary GH insensitivity). Clin Endocrinol 65: 114-117. (Pubitemid 43911688)
20. Laron Z, Klinger B, 1993 Body fat in Laron syndrome patients:effect of insulin like growth factor I treatment. Hormone Res 40: 16-22. (Pubitemid 23349938)
21. Laron Z, Avitzur Y, Klinger B, 1995 Carbohydrate metabolism in primary growth hormone resistance (Laron syndrome) before and during insulin like growth factor I treatment. Metabolism 44: 113-118.
22. Laron Z, Weinberger D, 2004 Diabetic retinopathy in two patients with congenital IGF1 deficiency (Laron syndrome). Europ J Endocrinol 151: 103-106. (Pubitemid 39117370)
23. Rosenbloom AL, Guevara-Aguirre J, Rosenfeld RG, Francke U, 1999 Growth hormone receptor deficiency in Ecuador. J Clin Endocrinol Metab 84: 4436-4443. (Pubitemid 30677656)
24. Guevara-Aguirre J, Guevara-Aguirre M, Saavedra J, Bernstein G, 2007 Low serum levels of IGF-1, BP3 and ALS are associated to severe short stature, obesity, premature aging, increased cardiovascular mortality and absence of cancer in the Ecuadorian cohort of Laron syndrome subjects. Horm Res 68: 175.
25. Laron Z, Ginsberg S, Lilos P, Arbiv M, Vaisman N, 2006 Long term IGF1 treatment of children with Laron syndrome increases adiposity. Growth Horm IGF Res 16: 61-64. (Pubitemid 43205316)
26. Rosenbloom AL, Guevara-Aguirre J, Rosenfeld RG, Fielder PJ, 1990 The little women of Loja - growth hormone receptor deficiency in an inbred population of Southern Ecuador. N Engl J Med 323: 1367-1374.
27. Tatar M, Bartke A, Antebi A, 2003 The endocrine regulation of aging by insulin like signals. Science 299: 1346-1351. (Pubitemid 36254639)
28. Al-Regaiey KA, Masternak MM, Bonkowski M, Sun L, Bartke A, 2005 Long lived growth hormone receptor knockout mice: interaction of reduced insulin like growth factor I/insulin signaling and caloric restriction. Endocrinology 146: 851-860. (Pubitemid 40129843)
29. Shevah O, Rubinstein M, Laron Z, 2004 Molecular defects of the growth hormone receptor gene, including a new mutation, in Laron syndrome patients in Israel: relationship between defects and ethnic groups. Isr Med Assoc J 6: 630-633. (Pubitemid 39334929)
30. Rosen T, Bengtsson BA, 1990 Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336: 285-288. (Pubitemid 20229130)
31. Tomlison JW, Holden N, Hills RK, et al, 2001 Association between premature mortality and hypopituitarism. Lancet 357: 425-431.
32. Shevah O, Laron Z, 2007 Patients with congenital deficiency of IGF1 seem protected from the development of malignancies: a preliminary report Growth Horm IGF Res 17: 54-57.
33. Christiensen K, Vaupel JW, 1996 Determinants of longevity: genetic, environmental and medical factors. J Int Med 240: 333-341. (Pubitemid 27008406)